Loading your page…

Pharmaceutical group

Fosun

10 medicines4 countries

A group of 4 companies with 10 medicines in 4 countries.

Its medicines

Group structure

4 companies in 2 countries

United States3

Poland1

Fosun Pharma Sp. Z O.O.Authorisation holder · 4 medicines

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

10 medicines

Medicine	Substance	Country	Status	Authorised
ACETAMINOPHEN AND CODEINE PHOSPHATE300MG; 15MG \| 300MG; 30MG \| 300MG; 60MG \| 325MG; 15MG \| 325MG; 30MG \| 325MG; 45MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 500MG; 15MG \| 500MG; 30MG \| 500MG; 60MG \| 650MG; 30MG \| 650MG; 60MG · Tablet	Paracetamol, Codeine	United States	Marketed	1976
ARISTOCORT25MG/ML \| 40MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Injectable	Triamcinolone	United States	Not marketed	1959
DAPTOMICINA FOSUN PHARMA 350 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG350 mg · Polvo para solución inyectable y para perfusión	Daptomycin	Spain	Authorised	2022
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE0.025mg; 2.5mg · Tablet	Atropine, Diphenoxylate	United States	Marketed	1977
LONOX0.025mg; 2.5mg · Tablet	Atropine, Diphenoxylate	United States	Not marketed	1977
OXALIPLATINO FOSUN PHARMAConcentrato per soluzione per infusione	Oxaliplatin	Italy	Authorised
Voriconazol Fosun Pharma 200 mg, poeder voor oplossing voor infusiePoeder voor oplossing voor infusie	Voriconazole	Netherlands	Authorised	2021
VORICONAZOL FOSUN PHARMA 200 MG POLVO PARA SOLUCION PARA PERFUSION EFG200 mg · Polvo para solución para perfusión	Voriconazole	Spain	Authorised	2022
APIXABAN1.5mg \| 2.0mg \| 2.5mg \| 5mg · Tablet	Apixaban	United States	tentative	2025
SITAGLIPTIN100mg \| 50mg · Tablet	Sitagliptin	United States	tentative	2026

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	6	4	2	Companies All medicines
Spain	2	2	0	Companies All medicines
Italy	1	1	0	Companies All medicines
Netherlands	1	1	0	Companies All medicines

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Fosun

Group structure

United States3

Poland1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇺🇸United States3

🇵🇱Poland1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

United States3

Poland1